Folic acid supplementation for pregnant women and those planning pregnancy: 2015 update
暂无分享,去创建一个
G. Koren | S. Vohra | D. Chitayat | Y. Amitai | M. Rieder | D. Kennedy | D. Matsui
[1] G. Koren,et al. Dose-Dependent Risk of Malformations With Antiepileptic Drugs: An Analysis of Data From the EURAP Epilepsy and Pregnancy Registry , 2015, Therapeutic drug monitoring.
[2] G. Koren,et al. Association Between Use of Oral Contraceptives and Folate Status: A Systematic Review and Meta-Analysis. , 2015, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.
[3] G. Koren,et al. Pregnancy‐induced changes in the long‐term pharmacokinetics of 1.1 mg vs. 5 mg folic acid: A randomized clinical trial , 2015, Journal of clinical pharmacology.
[4] R. Kirby,et al. Updated Estimates of Neural Tube Defects Prevented by Mandatory Folic Acid Fortification — United States, 1995–2011 , 2015, MMWR. Morbidity and mortality weekly report.
[5] Figo Working Group On Best Practice In Maternal-Fe. Best practice in maternal–fetal medicine , 2015, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[6] A. Tardón,et al. Folic acid supplements during pregnancy and child psychomotor development after the first year of life. , 2014, JAMA pediatrics.
[7] H. Boezen,et al. Maternal high‐dose folic acid during pregnancy and asthma medication in the offspring , 2014, Pharmacoepidemiology and drug safety.
[8] O. Devine,et al. Population red blood cell folate concentrations for prevention of neural tube defects: bayesian model , 2014, BMJ : British Medical Journal.
[9] Zhi-Ping Wang,et al. Maternal passive smoking during pregnancy and neural tube defects in offspring: a meta-analysis , 2014, Archives of Gynecology and Obstetrics.
[10] M. Werler,et al. The impact of folic acid intake on the association among diabetes mellitus, obesity, and spina bifida. , 2013, American journal of obstetrics and gynecology.
[11] Zhi-Ping Wang,et al. Maternal overweight and obesity and the risk of neural tube defects: a case-control study in China. , 2013, Birth defects research. Part A, Clinical and molecular teratology.
[12] K. Bradbury,et al. Differences in erythrocyte folate concentrations in older adults reached steady-state within one year in a two-year, controlled, 1 mg/d folate supplementation trial. , 2012, The Journal of nutrition.
[13] A. Ly,et al. Folate and DNA methylation. , 2012, Antioxidants & redox signaling.
[14] Burcu Kara,et al. Simultaneous folate intake may prevent advers effect of valproic acid on neurulating nervous system , 2012, Child's Nervous System.
[15] T. Tomson,et al. Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry , 2011, The Lancet Neurology.
[16] D. Maneval,et al. MTHFR 677C->T genotype is associated with folate and homocysteine concentrations in a large, population-based, double-blind trial of folic acid supplementation. , 2011, The American journal of clinical nutrition.
[17] G. Koren,et al. Folate intake and the risk of colorectal cancer: a systematic review and meta-analysis. , 2011, Cancer epidemiology.
[18] P. Hider,et al. Folic acid supplementation and colorectal cancer risk: a meta‐analysis , 2011, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.
[19] W. Willett,et al. Pooled analyses of 13 prospective cohort studies on folate intake and colon cancer , 2010, Cancer Causes & Control.
[20] G. Koren,et al. Exposure to folic acid antagonists during the first trimester of pregnancy and the risk of major malformations. , 2009, British journal of clinical pharmacology.
[21] L. Bailey,et al. Folate in Health and Disease , 2009 .
[22] A. Ren,et al. Association of reduced folate carrier gene polymorphism and maternal folic acid use with neural tube defects , 2009, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[23] G. Koren,et al. Predictors of Prenatal Multivitamin Adherence in Pregnant Women , 2009, Journal of clinical pharmacology.
[24] G. Koren,et al. Steady state folate concentrations achieved with 5 compared with 1.1 mg folic acid supplementation among women of childbearing age. , 2009, The American journal of clinical nutrition.
[25] R. Rozen,et al. Valproic acid increases expression of methylenetetrahydrofolate reductase (MTHFR) and induces lower teratogenicity in MTHFR deficiency , 2008, Journal of cellular biochemistry.
[26] G. Koren,et al. Folate fortification and supplementation--are we there yet? , 2008, Reproductive toxicology.
[27] B. de Benoist. Conclusions of a WHO Technical Consultation on Folate and Vitamin B12 Deficiencies , 2008, Food and nutrition bulletin.
[28] E. Merello,et al. Evaluation of a methylenetetrahydrofolate-dehydrogenase 1958G>A polymorphism for neural tube defect risk , 2006, Journal of Human Genetics.
[29] G. Koren,et al. Celiac disease during pregnancy. , 2004, Canadian family physician Medecin de famille canadien.
[30] J. M. Sequeira,et al. Autoantibodies against folate receptors in women with a pregnancy complicated by a neural-tube defect. , 2004, The New England journal of medicine.
[31] S. Buyske,et al. New 19 bp deletion polymorphism in intron‐1 of dihydrofolate reductase (DHFR): A risk factor for spina bifida acting in mothers during pregnancy? , 2004, American journal of medical genetics. Part A.
[32] G. Shaw,et al. Associations between polymorphisms within the thymidylate synthase gene and spina bifida. , 2003, Birth defects research. Part A, Clinical and molecular teratology.
[33] R. Finnell,et al. Reduced folate carrier polymorphism (80A→G) and neural tube defects , 2003, European Journal of Human Genetics.
[34] R. Finnell,et al. Study of MTHFR and MS polymorphisms as risk factors for NTD in the Italian population , 2002, Journal of Human Genetics.
[35] G. Shaw,et al. Maternal periconceptional vitamin use, genetic variation of infant reduced folate carrier (A80G), and risk of spina bifida. , 2002, American journal of medical genetics.
[36] M. Law,et al. Quantifying the effect of folic acid , 2001, The Lancet.
[37] Quanhe Yang,et al. 5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review. , 2000, American journal of epidemiology.
[38] M. Werler,et al. Achieving a public health recommendation for preventing neural tube defects with folic acid. , 1999, American journal of public health.
[39] D. Weir,et al. Folate levels and neural tube defects. Implications for prevention. , 1995, JAMA.
[40] A. Czeizel,et al. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. , 1992, The New England journal of medicine.
[41] M. Gnant,et al. Prevention of neural tube defects: Results of the Medical Research Council Vitamin Study , 1991, The Lancet.
[42] Zhiping Wang,et al. High dose of maternal folic acid supplementation is associated to infant asthma. , 2015, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[43] A. Carriquiry,et al. Folic acid source, usual intake, and folate and vitamin B-12 status in US adults: National Health and Nutrition Examination Survey (NHANES) 2003-2006. , 2010, The American journal of clinical nutrition.
[44] G. Koren,et al. Comparing folic acid pharmacokinetics among women of childbearing age: single dose ingestion of 1.1 versus 5 MG folic acid. , 2008, The Canadian journal of clinical pharmacology = Journal canadien de pharmacologie clinique.
[45] G. Steger,et al. Folate absorption in Crohn's disease. , 1994, Digestion.